Cargando…
Allele-Specific Gene Editing Rescues Pathology in a Human Model of Charcot-Marie-Tooth Disease Type 2E
Many neuromuscular disorders are caused by dominant missense mutations that lead to dominant-negative or gain-of-function pathology. This category of disease is challenging to address via drug treatment or gene augmentation therapy because these strategies may not eliminate the effects of the mutant...
Autores principales: | Feliciano, Carissa M., Wu, Kenneth, Watry, Hannah L., Marley, Chiara B. E., Ramadoss, Gokul N., Ghanim, Hana Y., Liu, Angela Z., Zholudeva, Lyandysha V., McDevitt, Todd C., Saporta, Mario A., Conklin, Bruce R., Judge, Luke M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415563/ https://www.ncbi.nlm.nih.gov/pubmed/34485306 http://dx.doi.org/10.3389/fcell.2021.723023 |
Ejemplares similares
-
Challenges in modelling the Charcot-Marie-Tooth neuropathies for therapy development
por: Juneja, Manisha, et al.
Publicado: (2019) -
SIRT2‐knockdown rescues GARS‐induced Charcot‐Marie‐Tooth neuropathy
por: Zhao, Yingying, et al.
Publicado: (2021) -
Diagnosis of Charcot-Marie-Tooth Disease
por: Banchs, Isabel, et al.
Publicado: (2009) -
Diseased, differentiated and difficult: Strategies for improved engineering of in vitro neurological systems
por: Elder, Nicholas, et al.
Publicado: (2022) -
The allelic spectrum of Charcot–Marie–Tooth disease in over 17,000 individuals with neuropathy
por: DiVincenzo, Christina, et al.
Publicado: (2014)